Patrick G Johnston

Title: The Innovations of Patrick G Johnston

Introduction

Patrick G Johnston is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work has implications for cancer diagnostics and treatment.

Latest Patents

One of Johnston's latest patents is focused on monoclonal antibodies specific for human thymidylate synthase. This invention relates to the production of monoclonal antibodies that target the protein thymidylate synthase, along with hybridomas that produce these antibodies. The patent also includes methods for detection and diagnostic kits designed to test for the presence of thymidylate synthase, which is crucial in identifying colon carcinoma cells. Another significant patent involves methods for predicting the efficacy of chemotherapeutic regimens for patients with gastrointestinal cancers. This innovation provides a framework for determining the appropriateness of chemotherapeutic treatments for affected patients.

Career Highlights

Throughout his career, Johnston has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to contribute to important advancements in medical research and patient care.

Collaborations

Johnston has collaborated with notable colleagues such as Carmen J Allegra and Edwin R Fisher. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Patrick G Johnston's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer diagnostics and treatment methodologies.